Rare diseases
Investigational molecules
Locations
Study on Avelumab for Patients with High-Risk Triple Negative Breast Cancer
ItalyStudy of Encorafenib, Cetuximab, and Pembrolizumab for Patients with Untreated BRAF V600E-Mutant Metastatic Colorectal Cancer
ItalyStudy of Acalabrutinib and Tafasitamab for Patients with Previously Treated Marginal Zone Lymphoma
ItalyStudy Comparing Axicabtagene Ciloleucel with Standard Treatment for Patients with Relapsed or Refractory Follicular Lymphoma
ItalyStudy Comparing Abelacimab and Apixaban for Preventing Blood Clots in Cancer Patients
ItalyStudy on Abelacimab and Dalteparin for Preventing Blood Clots in Patients with Gastrointestinal or Genitourinary Cancer
ItalyStudy on Loncastuximab Tesirine for Patients with Relapsed or Refractory Mantle Cell Lymphoma After Immunochemotherapy with Rituximab, Bendamustine, and Cytarabine
ItalyStudy Comparing Carfilzomib, Lenalidomide, and Dexamethasone with Lenalidomide and Dexamethasone for Newly Diagnosed Multiple Myeloma Patients Ineligible for Transplant
ItalyStudy on Restoring Immunotherapy Sensitivity in Advanced Triple Negative Breast Cancer Using Ceralasertib, Durvalumab, and Paclitaxel Albumin-Bound
ItalyStudy on the Effects and Safety of Efgartigimod PH20 SC for Adults with Active Idiopathic Inflammatory Myopathy
ItalyStudy of ELVN-002 with Trastuzumab and Chemotherapy for Patients with Advanced HER2+ Solid Tumors, Colorectal Cancer, and Breast Cancer
ItalyStudy on Anifrolumab for Adults with Chronic or Subacute Cutaneous Lupus Erythematosus Unresponsive to Antimalarial Therapy
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.
